ated with altered glycolysis, such as central nervous system disorders, cancer, and ina m m a t i o n . We discuss in detail in this Focus recent e orts to image infection and in ammation, including recent papers on detecting acute infective endocarditis with advanced imaging methods, such as PET.
VISUALIZING INFECTION AND INFLAMMATION
In the 1930s, Warburg discovered increased glycolysis in cancer cells in vitro. It was noted therea er that in ammatory cells also have high glycolytic activity that is similar to that of malignant cells (2) (3) (4) . In recent years, the range of disorders with aberrant glycolysis that can be assessed by means of FDG-PET has increased and comprises common infections (such as an infected prosthesis, osteomyelitis, or a diabetic foot) and noninfectious in ammatory disorders, such as rheumatoid arthritis, regional ileitis, sarcoidosis, and atherosclerosis (4) . FDG as a unique tracer has been used extensively for identi cation of infected sites in the human body and for monitoring response to treatment (3, 4) .
Two types of biological structures at the site of infection can be targeted with external imaging. One is microorganisms, such as bacteria; the other is in ammatory cells that home to the infected site. Although either of these could potentially serve as a reliable source for targeted imaging, there are major di erences between the two with regard to modern imaging techniques. For example, the volume of microorganisms that reside at these sites is extremely small and provides limited options for detecting the infected areas (because few binding sites are available). Conversely, imaging in ammatory cells has proven to be relatively effective, as shown by a variety of approaches, in particular functional imaging techniques that use radiotracers. Nevertheless, detecting in ammatory cells is nonspeci c and provides indirect evidence at best for local or di use infection. In other words, simply visualizing the presence of immune cells cannot di erentiate between in ammation caused by microorganisms or by noninfectious diseases.
E orts to radiolabel bacteria at the sites of infection have yielded minimal success, and most have not been translated into the clinic.
is approach was adopted using single gamma-emitting radionuclides attached to bacteria-targeting compounds, including antibiotics (5) . In recent years, e orts have been made to use positronemitting radiotracers instead because of favorable physicochemical characteristics. With the radiolabled tracers, it is clear that positive results, which were reported by this approach, mostly re ected nonspeci c leakage of the labeled agents at the sites of infection owing to the presence of a large number of leaky vessels. In other words, similar and positive results would be expected to be noted from inert preparations with no known attraction to the site, such as radiolabeled albumin. erefore, there is some consensus that compounds that target bacteria and other microorganisms may not be promising enough to be pursued further at this time.
ere are two possible options for visualizing in ammatory cells at the infected sites. One method is to label a patient's white cells ex vivo, reinfuse them intravenously, and monitor cell migration to the infected lesions by using conventional scintillation cameras. Unfortunately, there are serious shortcomings to this approach. e procedure is very time-consuming (3 to 5 hours for labeling, 24 hours for imaging), which results in many nonfunctional cells. In addition, the image quality is very poor (nontomographic), and the radiation dose to the sensitive organs is unacceptably high. e other option is to label white cells with positron-emitting compounds, such as FDG, and to image with PET. is method has also experienced minimal success. Because of these limitations to ex vivo labeling and positron-emitting labels, others have explored radiolabeled nanoparticles and FDG for visualizing immune response and in ammation. Further research is needed to determine the viability of this nanoparticlebased technique for routine use in humans. This Focus discusses the merits of modern imaging techniques for the management of patients with suspected or proven infection and also addresses the challenges of detecting infective endocarditis early. FOCUS endocarditis has been limited. Acute endocarditis is classically de ned as in ammation of the endocardium (inner layer of the heart) and is a major clinical problem that progresses rapidly. Vegetations, the hallmark lesions of endocarditis, are composed of platelets, -brin, microorganisms, and in ammatory cells. Endocarditis occurs as a result of implantation of circulating bacteria on the cardiac or aortic valves that have entered the bloodstream from the mouth cavity or the gastrointestinal tracts. Moreover, preexisting damage to the valve is considered a predisposing factor for infection. Of all of the modern structural imaging techniques, echocardiography (particularly the transesophageal approach) has been the most successful in identifying vegetative lesions present in the valves of the heart and the aorta in patients with endocarditis. Unfortunately, because of the small size of the lesions (several millimeters), a large number of lesions go undetected. In addition, structural imaging is nonspeci c, cannot di erentiate between active and inactive infection, and is unable to assess response to systemic therapy. erefore, there is an unmet need for methodologies that allow timely detection of endocarditis and its complications, such as embolic lesions at distant locations, and also monitor response to treatment.
FOCUSING IN ON ENDOCARDITIS
A recent technical report by Panizzi et al. (6) describes in vivo detection of endocarditis caused by coagulase-positive Staphylococcus aureus, which is the most dangerous and virulent type that might not respond readily to treatment. e authors introduce an interesting method that incorporates both noninvasive uorescence and PET imaging to visualize growing bacterial vegetations. First, a mouse model of S. aureus endocarditis was developed that recapitulates the bacterial lesions seen in the human condition. Because S. aureus is able to induce blood coagulation via staphylocoagulase, Panizzi et al. created a uorescent prothrombin-based probe that could be activated in vivo by the enzyme. When injected into mice with endocarditis, the probe deposited at the sites of vegetation (damaged endothelium) and uoresced brightly in ex vivo sections of the mouse aortas (6) . A faint response was also noticeable in mice infected with coagulase-negative Staphylococcus epidermidis, but none at all was seen in uninfected control mice.
e goal is to use this noninvasive imaging method for diagnosis of endocarditis in humans. To this end, the authors used their prothrombin probe with uorescence molecular tomography combined with x-ray computed tomography (FMT-CT) to image bacterial growths in vivo in living mice.
ey were able to con rm the presence of such vegetations 24 hours a er injection with high speci city and high signal over background when compared with various control animals. Furthermore, Panizzi and colleagues were able to visualize in vivo the response to treatment with the antibiotic vancomycin, which resulted in a decrease in signal over the course of 48 hours. Lastly, a new prothrombin-based probe was generated for PET-CT imaging, which allowed for radiological imaging with standard instrumentation widely available in clinics. is radiolabeled prothrombin probe was similarly able to con rm the presence of vegetations in damaged aortas in living mice.
e observations made in mice with experimental endocarditis using both FMT-CT and PET-CT imaging are intriguing and innovative and may provide a powerful means for assessing this potentially lifethreatening infectious disease in humans. It is important moving forward that this approach be tested in larger animals in order to determine the merit of optical imaging in detecting lesions that are distant from the imaging devices. Translation of this approach would also entail further clarifying the speci city of this tracer for S. aureus and no other bacteria. Panizzi et al. tested their agent in coagulasenegative S. epidermidis-infected mice, which argues for the speci city of the agent. However, the fact that the S. epidermidis vegetations accumulated a small amount of tracer (albeit much less than S. aureus) would be one reason to examine this in larger vegetation to ensure that the partial-volume e ect common to imaging is not playing a role in the minimal visualization of vegetation.
TRANSLATIONAL CHALLENGES AND PROSPECTS
FDG in combination with PET-CT has also been used to identify vegetative lesions in the human heart, as well as at distant sites, owing to embolization of detached lesions (7) (8) (9) (10) . FDG binds to both clots and in ammatory cells and has therefore been used with great interest. Early clinical trial observations using FDG-PET show promise for the routine, noninvasive detection of endocarditis (7-10). As shown in Fig. 1 , FDG-PET-CT was used to detect suspected infective endocarditis in a 47-year-old woman (7). One hour a er injection, there was substantial uptake of FDG in the infected areas of the aortic valve, which was con rmed with separate blood cultures to be coagulase-negative Staphylococci. Other single-case studies have described the applicability of FDG-PET for diagnosing infection in the heart (8-10), especially when echocardiography presents unclear results, such as in the case of patients with prosthetic vales or indwelling pacemakers (7) . e method described by Panizzi et al. allows for concurrent imaging to detect vegetative lesions and con rmation of the type of bacteria present by use of the prothrombin dye. is multifaceted approach is promising for early detection and treatment in humans; however, further validation will be needed to assess its utility in routine diagnosis. e major concern is that a very small fraction of the vegetations might be stained super cially with the compounds described, which may not be resolved by existing PET imaging instruments. erefore, there is a need for novel imaging e orts that overcome some of the de ciencies associated with PET and CT. e major challenges of visualizing relatively small lesions, such as vegetations due to endocarditis in the heart and aortic valves, are twofold: the size of the abnormalities to be detected and the constant rhythmic motion of the heart. Although modern structural imaging modalities, such as CT and ultrasound, have high spatial resolution and can generate scans quickly, they lack high-contrast resolution and therefore su er from low sensitivity in detecting these lesions.
PET-CT has the greatest potential for overcoming these de ciencies and should be pursued as a viable option for managing patients with this serious heart infection. Newly developed PET compounds should label the entire lesion and not bind supercially to the surface. At present, the suboptimal spatial resolution of PET (around several millimeters under ideal conditions) in detecting small lesions will prevent the accurate diagnosis of endocarditis. To overcome further deterioration of image quality owing to cardiac motion, gated imaging based on cardiac cycle by using ECG may improve image resolution and, in turn, the sensitivity of the PET-based approach. Assessing global disease activity in the entire heart may prove to be a possibility in this setting.
As described in this Focus, there are several emerging and novel approaches to diagnosing and treating infective endocarditis early (6-10). Large-scale, prospective multicenter trials should be carried out to de ne the merits of these novel imaging methodologies in the near future. Until more human trials are undertaken, the potential role and bene t of such approaches in the clinic will remain unclear.
